{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:04:29Z","timestamp":1773086669330,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1007\/s11912-006-0061-1","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T14:39:05Z","timestamp":1180795145000},"page":"376-386","source":"Crossref","is-referenced-by-count":30,"title":["Mycosis fungoides and sezary syndrome: An update"],"prefix":"10.1007","volume":"8","author":[{"given":"Ellen J.","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline M. Junkins-","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela C.","family":"Vittorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"61_CR1","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra032810","volume":"35","author":"M Girardi","year":"2004","unstructured":"Girardi, M, Heald PW, Wilson LD: The pathogenesis of mycosis fungoides. N Engl J Med 2004, 35:1978\u20131988. A lucid, comprehensive review of the basic science advances in MF\/SS.","journal-title":"N Engl J Med"},{"key":"61_CR2","doi-asserted-by":"crossref","unstructured":"WHO-EORTC classification for cutaneous lymphomas. Blood 2005, 105:3768\u20133785. The new joint classification system is a step in the right direction for clarifying cutaneous lymphomas.","DOI":"10.1182\/blood-2004-09-3502"},{"key":"61_CR3","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","volume":"53","author":"N Pimpinelli","year":"2005","unstructured":"Pimpinelli N, Olsen EA, Santucci M, et al.: Defining early mycosis fungoides. J Am Acad Dermatol 2005, 53:1053\u20131063.","journal-title":"J Am Acad Dermatol"},{"key":"61_CR4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/1523-1747.ep12389114","volume":"103","author":"GS Wood","year":"1994","unstructured":"Wood GS, Tung RM, Haeffner AC, et al.: Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides\/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR\/DGGE). J Invest Dermatol 1994, 103: 34\u201341.","journal-title":"J Invest Dermatol"},{"key":"61_CR5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2133.2005.06649.x","volume":"153","author":"R Ponti","year":"2005","unstructured":"Ponti R, Quaglino P, Novelli M, et al.: T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction\/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides\/Sezary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings. Br J Dermatol 2005, 153:565\u2013573.","journal-title":"Br J Dermatol"},{"key":"61_CR6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2133.2005.06760.x","volume":"153","author":"E Alessi","year":"2005","unstructured":"Alessi E, Coggi A, Venegoni L, et al.: The usefulness of clonality for the detection of cases clinically and\/or histopathologically not recognized as cutaneous T-cell lymphoma. Br J Dermatol 2005, 153: 368\u2013371.","journal-title":"Br J Dermatol"},{"issue":"9","key":"61_CR7","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archderm.141.9.1159","volume":"141","author":"J Guitart","year":"2005","unstructured":"Guitart J: Beyond clonal detection: defining the T-cell clone. Arch Dermatol 2005, 141(9):1159\u20131160. A concise summary of the current role of T-cell receptor clonality in MF\/SS diagnosis and prognosis.","journal-title":"Arch Dermatol"},{"key":"61_CR8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5858\/2005-129-372-UOCTCA","volume":"129","author":"N Cordel","year":"2005","unstructured":"Cordel N, Lenormand B, Courville P, et al.: Usefulness of cutaneous T-cell clonality analysis for the diagnosis of cutaneous T-cell lymphoma in patients with erythroderma. Arch Pathol Lab Med 2005, 129:372\u2013376.","journal-title":"Arch Pathol Lab Med"},{"key":"61_CR9","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2002-11-3574","volume":"102","author":"L Tracey","year":"2003","unstructured":"Tracey L, Villuendas R, Dotor AM, et al.: Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. Blood 2003, 102:1042\u20131050. One of three studies that demonstrate the power of microarray analysis as applied to MF\/SS. See [10,11].","journal-title":"Blood"},{"key":"61_CR10","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1084\/jem.20021726","volume":"197","author":"L Kari","year":"2003","unstructured":"Kari L, Loboda A, Nebozhyn M, et al.: Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med 2003, 197:1477\u20131488. One of three studies that demonstrate the power of microarray analysis as applied to MF\/SS. See [9,11].","journal-title":"J Exp Med"},{"key":"61_CR11","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2005-07-2813","volume":"107","author":"M Nebozhyn","year":"2006","unstructured":"Nebozhyn M, Loboda A, Kari L, et al.: Quantitative PCR on 5 genes reliably identifies CTCL patients with 5\u201399% circulating tumor cells with 90% accuracy. Blood 2006, 107:3189\u20133196. One of three studies that demonstrate the power of microarray analysis as applied to MF\/SS. See [9,10].","journal-title":"Blood"},{"key":"61_CR12","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0889-8588(03)00120-5","volume":"17","author":"EC Vonderheid","year":"2003","unstructured":"Vonderheid EC, Bernengo MG: The Sezary syndrome: hematologic criteria. Hematol Oncol Clin North Am 2003, 17:1367\u20131389, viii. An update of the B classification system for MF\/SS that reflects the newer diagnostic techniques.","journal-title":"Hematol Oncol Clin North Am"},{"key":"61_CR13","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/j.1365-2133.2005.06621.x","volume":"152","author":"M Beylot-Barry","year":"2005","unstructured":"Beylot-Barry M, Parrens M, Delaunay M, et al.: Is bone marrow biopsy necessary in patients with mycosis fungoides and Sezary syndrome? A histological and molecular study at diagnosis and during follow-up. Br J Dermatol 2005, 152:1378\u20131379.","journal-title":"Br J Dermatol"},{"key":"61_CR14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, et al.: Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001. Blood 2006, 107:265\u2013276.","journal-title":"Blood"},{"key":"61_CR15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000088501","volume":"211","author":"MM Morales","year":"2005","unstructured":"Morales MM, Putcha V, Evans HS, et al.: Survival of mycosis fungoides in patients in the Southeast of England. Dermatology 2005, 211:325\u2013329.","journal-title":"Dermatology"},{"key":"61_CR16","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood-2005-03-1180","volume":"107","author":"RK Gupta","year":"2006","unstructured":"Gupta RK, Ramble J, Tong CY, et al.: Cytomegalovirus seroprevalence is not higher in patients with mycosis fungoides\/Sezary syndrome. Blood 2006, 107:1241\u20131242.","journal-title":"Blood"},{"key":"61_CR17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bjc.6602997","volume":"94","author":"SM Tothova","year":"2006","unstructured":"Tothova SM, Bonin S, Trevisan G, Stanta G: Mycosis fungoides: is it a Borrelia burgdorferi-associated disease? Br J Cancer 2006, 94:879\u2013883.","journal-title":"Br J Cancer"},{"key":"61_CR18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/archderm.141.10.1235","volume":"141","author":"E Trento","year":"2005","unstructured":"Trento E, Castilletti C, Ferraro C, et al.: Human herpesvirus 8 infection in patients with cutaneous lymphoproliferative diseases. Arch Dermatol 2005, 141:1235\u20131242.","journal-title":"Arch Dermatol"},{"key":"61_CR19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s10552-005-0456-6","volume":"16","author":"MM Morales-Suarez-Varela","year":"2005","unstructured":"Morales-Suarez-Varela MM, Olsen J, Johansen P, et al.: Occupational exposures and mycosis fungoides. A European multicentre case-control study (Europe). Cancer Causes Control 2005, 16:1253\u20131259.","journal-title":"Cancer Causes Control"},{"key":"61_CR20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaad.2005.02.043","volume":"53","author":"A Schmidt","year":"2005","unstructured":"Schmidt A, Robbins J, Zic J: Transformed mycosis fungoides developing after treatment with alefacept. J Am Acad Dermatol 2005, 53:355\u2013356.","journal-title":"J Am Acad Dermatol"},{"key":"61_CR21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2133.2005.06686.x","volume":"153","author":"S Dalle","year":"2005","unstructured":"Dalle S, Balme B, Berger F, et al.: Mycosis fungoides-associated follicular mucinosis under adalimumab. Br J Dermatol 2005, 153:207\u2013208.","journal-title":"Br J Dermatol"},{"key":"61_CR22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2133.2005.06755.x","volume":"153","author":"D Abeni","year":"2005","unstructured":"Abeni D, Frontani M, Sampogna F, et al.: Circulating CD8+ lymphocytes, white blood cells, and survival in patients with mycosis fungoides. Br J Dermatol 2005, 153:324\u2013330.","journal-title":"Br J Dermatol"},{"key":"61_CR23","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archderm.141.9.1107","volume":"141","author":"T Juarez","year":"2005","unstructured":"Juarez T, Isenhath SN, Polissar NL, et al.: Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods. Arch Dermatol 2005, 141:1107\u20131113.","journal-title":"Arch Dermatol"},{"key":"61_CR24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1182\/blood-2004-06-2220","volume":"105","author":"C Assaf","year":"2005","unstructured":"Assaf C, Hummel M, Steinhoff M, et al.: Early TCR-beta and TCR-gamma PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications. Blood 2005, 105:503\u2013510.","journal-title":"Blood"},{"key":"61_CR25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2133.2005.06676.x","volume":"153","author":"CD Klemke","year":"2005","unstructured":"Klemke CD, Mansmann U, Poenitz N, et al.: Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sezary syndrome. Br J Dermatol 2005, 153:118\u2013124. This paper offers a revised severity index that, if further validated, could be a valuable tool in future clinical trials and outcome studies.","journal-title":"Br J Dermatol"},{"key":"61_CR26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1310","volume":"4","author":"TS Kupper","year":"2004","unstructured":"Kupper TS, Fuhlbrigge RC: Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 2004, 4:211\u2013222. Excellent review of the role of skin-homing T cells.","journal-title":"Nat Rev Immunol"},{"key":"61_CR27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2133.2004.06325.x","volume":"152","author":"M Sokolowska-Wojdylo","year":"2005","unstructured":"Sokolowska-Wojdylo M, Wenzel J, Gaffal E, et al.: Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br J Dermatol 2005, 152:258\u2013264.","journal-title":"Br J Dermatol"},{"key":"61_CR28","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.jid.5700246","volume":"126","author":"S Kagami","year":"2006","unstructured":"Kagami S, Sugaya M, Minatani Y, et al.: Elevated serum CTACK\/CCL27 levels in CTCL. J Invest Dermatol 2006, 126:1189\u20131191.","journal-title":"J Invest Dermatol"},{"key":"61_CR29","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2230.2005.01904.x","volume":"30","author":"M Sokolowska-Wojdylo","year":"2005","unstructured":"Sokolowska-Wojdylo M, Wenzel J, Gaffal E, et al.: Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sezary syndrome. Clin Exp Dermatol 2005,30:702\u2013706.","journal-title":"Clin Exp Dermatol"},{"key":"61_CR30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaad.2005.06.001","volume":"53","author":"CE Introcaso","year":"2005","unstructured":"Introcaso CE, Hess SD, Kamoun M, et al.: Association of change in clinical status and change in the percentage of the CD4+CD26-lymphocyte population in patients with Sezary syndrome. J Am Acad Dermatol 2005, 53:428\u2013434.","journal-title":"J Am Acad Dermatol"},{"key":"61_CR31","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1182\/blood-2005-04-1492","volume":"107","author":"MG Narducci","year":"2006","unstructured":"Narducci MG, Scala E, Bresin A, et al.: Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26\/dipeptidylpeptidase IV. Blood 2006, 107:1108\u2013115. This paper elucidates the role of CD26 loss in SS.","journal-title":"Blood"},{"key":"61_CR32","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.0022-202X.2004.23586.x","volume":"124","author":"EC Vonderheid","year":"2005","unstructured":"Vonderheid EC, Boselli CM, Conroy M, et al.: Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphoma. J Invest Dermatol 2005, 124:651\u2013661.","journal-title":"J Invest Dermatol"},{"key":"61_CR33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.jid.5700122","volume":"126","author":"R Talpur","year":"2006","unstructured":"Talpur R, Jones DM, Alencar AJ, et al.: CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma. J Invest Dermatol 2006, 126:575\u2013583.","journal-title":"J Invest Dermatol"},{"key":"61_CR34","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330\u2013336.","journal-title":"Nat Immunol"},{"key":"61_CR35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.2004.04999.x","volume":"126","author":"K Karube","year":"2004","unstructured":"Karube K, Ohshima K, Tsuchiya T, et al.: Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia\/lymphoma cells. Br J Haematol 2004, 126:81\u201384.","journal-title":"Br J Haematol"},{"key":"61_CR36","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/sj.jid.5700121","volume":"126","author":"PT Walsh","year":"2006","unstructured":"Walsh PT, Benoit BM, Wysocka M, et al.: A role for regulatory T cells in cutaneous T-cell lymphoma: induction of a CD4 + CD25 + Foxp3+ T-cell phenotype associated with HTLV-1 infection. J Invest Dermatol 2006, 126:690\u2013692. One of two papers that explore the relationship between Treg cells and MF\/SS, an emerging area of research. See [37].","journal-title":"J Invest Dermatol"},{"key":"61_CR37","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","volume":"105","author":"CL Berger","year":"2005","unstructured":"Berger CL, Tigelaar R, Cohen J, et al.: Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 2005, 105:1640\u20131647. One of two papers that explore the relationship between Treg cells and MF\/SS, an emerging area of research. See [36].","journal-title":"Blood"},{"key":"61_CR38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/sj.jid.5700029","volume":"126","author":"HK Wong","year":"2006","unstructured":"Wong HK, Wilson AJ, Gibson HM, et al.: Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides\u2014cutaneous T cell lymphoma. J Invest Dermatol 2006, 126:212\u2013219.","journal-title":"J Invest Dermatol"},{"key":"61_CR39","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/1074-7613(95)90011-X","volume":"2","author":"SJ Szabo","year":"1995","unstructured":"Szabo SJ, Jacobson NG, Dighe AS, et al.: Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 1995, 2:665\u2013675.","journal-title":"Immunity"},{"key":"61_CR40","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.4049\/jimmunol.163.7.4073","volume":"163","author":"LC Showe","year":"1999","unstructured":"Showe LC, Fox FE, Williams D, et al.: Depressed IL-12-mediated signal transduction in T cells from patients with Sezary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. J Immunol 1999, 163:4073\u20134079.","journal-title":"J Immunol"},{"key":"61_CR41","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood-2002-01-0231","volume":"100","author":"M Wysocka","year":"2002","unstructured":"Wysocka M, Zaki MH, French LE, et al.: Sezary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines. Blood 2002, 100:3287\u20133294.","journal-title":"Blood"},{"key":"61_CR42","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI24826","volume":"115","author":"EJ Kim","year":"2005","unstructured":"Kim EJ, Hess S, Richardson SK, et al.: Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest 2005, 115:798\u2013812. This review summarizes the immunobiology of MF\/SS and the rationale behind combination therapy.","journal-title":"J Clin Invest"},{"key":"61_CR43","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1158\/1078-0432.CCR-05-1777","volume":"12","author":"K Yamanaka","year":"2006","unstructured":"Yamanaka K, Clark R, Dowgiert R, et al.: Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma. Clin Cancer Res 2006, 12:376\u2013382.","journal-title":"Clin Cancer Res"},{"key":"61_CR44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","volume":"378","author":"H Okamura","year":"1995","unstructured":"Okamura H, Tsutsi H, Komatsu T, et al.: Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378:88\u201391.","journal-title":"Nature"},{"key":"61_CR45","doi-asserted-by":"crossref","first-page":"13962","DOI":"10.1073\/pnas.96.24.13962","volume":"96","author":"T Yoshimoto","year":"1999","unstructured":"Yoshimoto T, Tsutsui H, Tominaga K, et al.: IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci U S A 1999, 96:13962\u201313966.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"61_CR46","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI115920","volume":"90","author":"A Dalloul","year":"1992","unstructured":"Dalloul A, Laroche L, Bagot M, et al.: Interleukin-7 is a growth factor for Sezary lymphoma cells. J Clin Invest 1992, 90:1054\u20131060.","journal-title":"J Clin Invest"},{"key":"61_CR47","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1182\/blood-2005-03-1139","volume":"107","author":"K Yamanaka","year":"2006","unstructured":"Yamanaka K, Clark R, Rich B, et al.: Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma. Blood 2006, 107:2440\u20132445.","journal-title":"Blood"},{"key":"61_CR48","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1182\/blood-2003-04-1044","volume":"102","author":"N Yawalkar","year":"2003","unstructured":"Yawalkar N, Ferenczi K, Jones DA, et al.: Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma. Blood 2003, 102:4059\u20134066. One of two papers that demonstrate that MF\/SS profoundly decreased normal T-cell repertoire, which may contribute to the immunosuppression observed in these patients. See [49].","journal-title":"Blood"},{"key":"61_CR49","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1158\/1078-0432.CCR-04-2514","volume":"11","author":"K Yamanaka","year":"2005","unstructured":"Yamanaka K, Yawalkar N, Jones DA, et al.: Decreased Tcell receptor excision circles in cutaneous T-cell lymphoma. Clin Cancer Res 2005, 11:5748\u20135755. One of two papers that demonstrate that MF\/SS profoundly decreased normal T-cell repertoire, which may contribute to the immunosuppression observed in these patients. See [48*].","journal-title":"Clin Cancer Res"},{"key":"61_CR50","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1517\/14728222.9.4.809","volume":"9","author":"RR Rosato","year":"2005","unstructured":"Rosato RR, Grant S: Histone deacetylase inhibitors: insights into mechanisms of lethality. Expert Opin Ther Targets 2005, 9:809\u2013824.","journal-title":"Expert Opin Ther Targets"},{"key":"61_CR51","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1200\/JCO.2005.11.353","volume":"23","author":"R Doorn van","year":"2005","unstructured":"van Doorn R, Zoutman WH, Dijkman R, et al.: Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol 2005, 23:3886\u20133896.","journal-title":"J Clin Oncol"},{"key":"61_CR52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.leukres.2005.08.012","volume":"30","author":"T Nagasawa","year":"2006","unstructured":"Nagasawa T, Zhang Q, Raghunath PN, et al.: Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing. Leuk Res 2006, 30:303\u2013312.","journal-title":"Leuk Res"},{"key":"61_CR53","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2005-06-2536","volume":"107","author":"A Sors","year":"2006","unstructured":"Sors A, Jean-Louis F, Pellet C, et al.: Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis. Blood 2006, 107:2354\u20132363.","journal-title":"Blood"},{"key":"61_CR54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archderm.141.3.305","volume":"141","author":"C. Rosen ST Querfeld","year":"2005","unstructured":"Querfeld C. Rosen ST, Kuzel TM, et al.: Long-term followup of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy. Arch Dermatol 2005, 141:305\u2013311.","journal-title":"Arch Dermatol"},{"key":"61_CR55","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-0609.2005.00497.x","volume":"75","author":"S Rupoli","year":"2005","unstructured":"Rupoli S, Goteri G, Pulini S, et al.: Long-term experience with low-dose interferon-alpha and PUVA in the management of early mycosis fungoides. Eur J Haematol 2005, 75:136\u2013145.","journal-title":"Eur J Haematol"},{"key":"61_CR56","first-page":"581","volume":"137","author":"M Duvic","year":"2001","unstructured":"Duvic M, Martin AG, Kim Y, et al.: Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch Dermatol 2001, 137:581\u2013593.","journal-title":"Arch Dermatol"},{"key":"61_CR57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/archderm.141.3.315","volume":"141","author":"JB Budgin","year":"2005","unstructured":"Budgin JB, Richardson SK, Newton SB, et al.: Biological effects of bexarotene in cutaneous T-cell lymphoma. Arch Dermatol 2005, 141:315\u2013321.","journal-title":"Arch Dermatol"},{"key":"61_CR58","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1182\/blood-2002-01-0300","volume":"100","author":"G Gorgun","year":"2002","unstructured":"Gorgun G, Foss F: Immunomodulatory effects of RXR rexinoids: modulation of high-affinity IL-2R expression enhances susceptibility to denileukin diftitox. Blood 2002, 100:1399\u20131403.","journal-title":"Blood"},{"key":"61_CR59","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood-2004-11-4570","volume":"106","author":"F Foss","year":"2005","unstructured":"Foss F, Demierre MF, DiVenuti G: A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma. Blood 2005, 106:454\u2013457.","journal-title":"Blood"},{"key":"61_CR60","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaad.2005.02.055","volume":"52","author":"SA Bouwhuis","year":"2005","unstructured":"Bouwhuis SA, Davis MD, el-Azhary RA, et al.: Bexarotene treatment of late-stage mycosis fungoides and Sezary syndrome: development of extracutaneous lymphoma in 6 patients. J Am Acad Dermatol 2005, 52:991\u2013996.","journal-title":"J Am Acad Dermatol"},{"key":"61_CR61","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaad.2003.10.669","volume":"50","author":"KS McGinnis","year":"2004","unstructured":"McGinnis KS, Junkins-Hopkins JM, Crawford G, et al.: Low-dose oral bexarotene in combination with lowdose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms. J Am Acad Dermatol 2004, 50:375\u2013379.","journal-title":"J Am Acad Dermatol"},{"key":"61_CR62","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jdermsci.2005.01.005","volume":"38","author":"R Hino","year":"2005","unstructured":"Hino R, Shimauchi T, Tokura Y: Treatment with IFNgamma increases serum levels of Th1 chemokines and decreases those of Th2 chemokines in patients with mycosis fungoides. J Dermatol Sci 2005, 38:189\u2013195.","journal-title":"J Dermatol Sci"},{"issue":"11","key":"61_CR63","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/cncr.21449","volume":"104","author":"E Marchi","year":"2005","unstructured":"Marchi E, Alinari L, Tani M, et al.: Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients. Cancer, 2005. 104(11): 2437\u20132441.","journal-title":"Cancer"},{"key":"61_CR64","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1200\/JCO.2005.02.774","volume":"23","author":"A Molina","year":"2005","unstructured":"Molina A, Zain J, Arber DA, et al.: Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides. J Clin Oncol 2005, 23:6163\u20136171. A retrospective review of eight patients treated with bone marrow\/ stem cell transplantation, which is increasingly considered for MF\/SS patients with refractory disease.","journal-title":"J Clin Oncol"},{"key":"61_CR65","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.0022-202X.2005.23925.x","volume":"125","author":"C Zhang","year":"2005","unstructured":"Zhang C, Richon V, Ni X, et al.: Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. J Invest Dermatol 2005, 125:1045\u20131052.","journal-title":"J Invest Dermatol"},{"key":"61_CR66","first-page":"7500","volume":"24","author":"E Olsen","year":"2006","unstructured":"Olsen E, Kim YH, Kuzel T, et al.: Vorinostat (suberoylanilide hydroxamic acid, SAHA) is clinically active in advanced cutaneous T-cell lymphoma (CTCL): Results of a phase IIb trial [abstract]. Proc ASCO 2006 24:7500.","journal-title":"Proc ASCO"},{"key":"61_CR67","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-8518-3-4","volume":"3","author":"M Salskov-Iversen","year":"2005","unstructured":"Salskov-Iversen M, Berger CL, Edelson RL: Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading. J Immune Based Ther Vaccines 2005, 3:4.","journal-title":"J Immune Based Ther Vaccines"},{"key":"61_CR68","first-page":"561","volume":"63","author":"SI Lamberg","year":"1979","unstructured":"Lamberg SI, Bunn PA Jr: Proceedings of the Workshop on Cutaneous T-cell Lymphomas (mycosis fungoides and Sezary syndrome). Cancer Treat Rep 1979, 63:561\u2013568.","journal-title":"Cancer Treat Rep"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-006-0061-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-006-0061-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-006-0061-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T18:55:39Z","timestamp":1707936939000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-006-0061-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["61"],"URL":"https:\/\/doi.org\/10.1007\/s11912-006-0061-1","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}